| RS2145526252 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS2145527060 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS2145527075 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS2145528028 |
WDR62
|
Health Risk |
Likely pathogenic |
Microcephaly 2, primary |
| RS2145530654 |
TAF4
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder, autosomal dominant 73 |
| RS2145532417 |
EFTUD2
|
Health Risk |
Pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS2145536487 |
TCN2
|
Health Risk |
Likely pathogenic |
Transcobalamin II deficiency, Transcobalamin II deficiency |
| RS2145536721 |
TCN2
|
Health Risk |
Pathogenic |
Transcobalamin II deficiency, Transcobalamin II deficiency |
| RS2145536823 |
TCN2
|
Health Risk |
Likely pathogenic |
— |
| RS2145537667 |
DYM
|
Health Risk |
Pathogenic |
Dyggve-Melchior-Clausen syndrome, Dyggve-Melchior-Clausen syndrome |
| RS2145541064 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial neonatal |
| RS2145541173 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS2145542063 |
KCNQ2
|
Health Risk |
Pathogenic |
KCNQ2-related disorder, KCNQ2-related disorder |
| RS2145542277 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial neonatal |
| RS2145544354 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS2145544570 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS2145544950 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS2145545066 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
RYR1-related disorder, Centronuclear myopathy |
| RS2145545140 |
TCN2
|
Health Risk |
Pathogenic |
Transcobalamin II deficiency, Transcobalamin II deficiency |
| RS2145547209 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS2145547234 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145547478 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145547497 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Seizure, Seizure |
| RS2145548128 |
TCN2
|
Health Risk |
Pathogenic |
Transcobalamin II deficiency, Transcobalamin II deficiency |
| RS2145548219 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145550047 |
TNPO2
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with hypotonia, impaired speech |
| RS2145550093 |
TNPO2
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with hypotonia, impaired speech |
| RS2145552247 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS2145552346 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS2145555670 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145556764 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145556956 |
KCNQ2
|
Health Risk |
Likely pathogenic |
— |
| RS2145557228 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145557980 |
UBA2
|
Health Risk |
Pathogenic |
ACCES syndrome, ACCES syndrome |
| RS2145558864 |
EFTUD2
|
Health Risk |
Pathogenic |
— |
| RS2145562180 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2145564113 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, RYR1-related disorder |
| RS2145567008 |
NOG
|
Health Risk |
Pathogenic |
Symphalangism-brachydactyly syndrome, Symphalangism-brachydactyly syndrome |
| RS2145567535 |
NOG
|
Health Risk |
Likely pathogenic |
Proximal symphalangism 1A, Proximal symphalangism 1A |
| RS2145567621 |
NOG
|
Health Risk |
Pathogenic |
NOG-related disorder, NOG-related disorder |
| RS2145578013 |
TRMT1
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder, autosomal recessive 68 |
| RS2145581806 |
EFTUD2
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2145582779 |
TNPO2
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with hypotonia, impaired speech |
| RS2145585588 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS2145586693 |
WDR62
|
Health Risk |
Pathogenic |
— |
| RS2145586826 |
WDR62
|
Health Risk |
Likely pathogenic |
Microcephaly 2, primary |
| RS2145586850 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2145587855 |
MYO18B
|
Health Risk |
Pathogenic |
Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome, Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome |
| RS2145591069 |
ATP6V0A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizure, Global developmental delay |
| RS2145591077 |
WDR62
|
Health Risk |
Likely pathogenic |
Abnormal cerebral morphology, Abnormal cerebral morphology |
| RS2145592791 |
SETBP1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 29 |
| RS2145593522 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2145595063 |
CD40
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3 |
| RS2145598769 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2145600541 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2145600619 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS2145601896 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS2145603843 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS2145606794 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related myopathy, RYR1-related myopathy |
| RS2145613542 |
TRIM37
|
Health Risk |
Likely pathogenic |
See cases, Mulibrey nanism syndrome |
| RS2145613555 |
BRD4
|
Health Risk |
Likely pathogenic |
— |
| RS2145613736 |
RTTN
|
Health Risk |
Pathogenic |
— |
| RS2145614282 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2145614578 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS2145620702 |
BCAS3;BCAS3-AS1
|
Health Risk |
Likely pathogenic |
Global developmental delay, Global developmental delay |
| RS2145621443 |
C19orf12
|
Health Risk |
Pathogenic |
Spastic ataxia, Spastic ataxia |
| RS2145623001 |
C19orf12
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 4, Neurodegeneration with brain iron accumulation 4 |
| RS2145623030 |
NACC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with epilepsy, cataracts |
| RS2145623385 |
NACC1
|
Health Risk |
Pathogenic |
— |
| RS2145623884 |
NACC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2145624427 |
NACC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2145625749 |
NACC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with epilepsy, cataracts |
| RS2145625752 |
NACC1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2145626399 |
NACC1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with epilepsy, cataracts |
| RS2145632623 |
GFAP
|
Health Risk |
Likely pathogenic |
Progressive ventriculomegaly, Progressive ventriculomegaly |
| RS2145632673 |
GFAP
|
Health Risk |
Pathogenic |
Alexander disease, Alexander disease |
| RS2145634031 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2145636004 |
RYR1
|
Health Risk |
Pathogenic |
— |
| RS2145636962 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145637388 |
GFAP
|
Health Risk |
Likely pathogenic |
Alexander disease, Alexander disease |
| RS2145637412 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS2145637592 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS2145637609 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145638522 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2145639419 |
C19orf12
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 43, Hereditary spastic paraplegia 43 |
| RS2145642617 |
GFAP
|
Health Risk |
Pathogenic |
Alexander disease, Alexander disease |
| RS2145643810 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS2145649990 |
SLC32A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Seizure |
| RS2145650002 |
SLC32A1
|
Health Risk |
Pathogenic |
Seizure, Intellectual disability |
| RS2145650130 |
SLC32A1
|
Health Risk |
Likely pathogenic |
Intellectual disability, Seizure |
| RS2145659049 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS2145662712 |
TMC8
|
Health Risk |
Pathogenic |
Epidermodysplasia verruciformis, Epidermodysplasia verruciformis |
| RS2145663047 |
RYR1
|
Health Risk |
Pathogenic |
Central core myopathy, RYR1-related disorder |
| RS2145663057 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2145664236 |
TMC8
|
Health Risk |
Likely pathogenic |
Epidermodysplasia verruciformis, Epidermodysplasia verruciformis |
| RS2145664555 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2145665305 |
STK4
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to STK4 deficiency, Combined immunodeficiency due to STK4 deficiency |
| RS2145667073 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2145667857 |
KDM4B
|
Health Risk |
Likely pathogenic |
— |
| RS2145671289 |
PLA2G6
|
Health Risk |
Likely pathogenic |
— |